Evidence map›Paper›PMID 39429204›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Homo-Nuclear Hetero-Atomic Conjugated Reticular Oligomers for Heterojunction: A Novel "Electron Medium" for Panel Photoelectrocatalysis.

Ruijuan Zhang, Boying Zhang, Haining Liu, Linda Jewell, Xinying Liu, Shanlin Qiao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Surfactant-Assisted Construction of Covalent Organic Frameworks.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruijuan ZhangCollege of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, China.
Boying ZhangCollege of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, China.
Haining LiuCollege of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, China.
Linda JewellInstitute for Catalysis and Energy Solutions, University of South Africa, Private Bag X6, Florida, 1710, South Africa.
Xinying LiuInstitute for Catalysis and Energy Solutions, University of South Africa, Private Bag X6, Florida, 1710, South Africa.ORCID https://orcid.org/0000-0002-1629-0298
Shanlin QiaoCollege of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, China.ORCID https://orcid.org/0000-0001-6523-1772

Funding

National Natural Science Foundation of China 22105058National Natural Science Foundation of China 22375056Natural Science Foundation of Hebei Province B2021208073
6 · The paper itself

Abstract

A substantial challenge in employing covalent organic frameworks (COFs) for photoelectrochemical (PEC) water splitting lies in improving their solution-processability while concurrently facilitating the transfer of charges and mass to the catalytic sites. Herein, we synthesize a solution-processable conjugated reticular oligomers (CROs), and further embed ruthenium (Ru) into the CRO, forming a CRO-Ru with homo-nuclear hetero-atomic. Thereafter, CRO and CRO-Ru construct an organic-organic heterojunction membrane at the nanoscale. This design achieves perfect lattice matching, significantly reducing the energy barrier of mass transfer, and effectively lowering the recombination rate of charge carriers. The optimized photocathode, CuI/CRO-Bpy:CRO-Bpy-Ru-1:1+P3HT/SnO

Indexed as

conjugated reticular oligomerscovalent organic frameworksheterojunctionsphotoelectrochemical water splittingsolution processability

Identifiers

PMID39429204
PMCPMC11633481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.